Mice homozygous for h/mCD22 and heterozygous for λ-myc developed systemic lymphadenopathy, splenomegaly, and bone marrow infiltration of a monomorphic h/mCD22+ B cell population between five to eight weeks of age (Figure S1). The gene discussed is MYCL; the disease is Splenomegaly.